⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17375061 | 1.00 | — | — | |
| SCHEMBL3628169 | 0.78 | — | — | |
| SCHEMBL13399574 | 0.78 | — | — | |
| SCHEMBL10497359 | 0.70 | — | — | |
| SCHEMBL14155584 | 0.70 | — | — | |
| SCHEMBL17920023 | 0.70 | — | — | |
| SCHEMBL17920145 | 0.70 | — | — | |
| SCHEMBL12450165 | 0.70 | — | — | |
| SCHEMBL7221033 | 0.70 | — | — | |
| SCHEMBL20029021 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114975098-A | Nanoimprint liquid material, method for producing pattern of cured product, and method for producing circuit board | 佳能株式会社 | 2022-08-30 | — | — | CN | disclosed |
| CN-107251193-B | Nanoimprint liquid material, method for producing pattern of cured product, method for producing optical component, and method for producing circuit board | 佳能株式会社 | 2022-06-21 | — | — | CN | disclosed |
| US-20160137610-A1 | Compounds that Modulate EGFR Activity and Methods for Treating or Preventing Conditions Therewith | Gatekeeper Pharmaceuticals, Inc. | 2016-05-19 | — | — | US | disclosed |
| WO-2016073652-A1 | IMINOSUGARS USEFUL FOR THE TREATMENT OF VIRAL DISEASES | UNITHER VIROLOGY, LLC (US) | 2016-05-12 | — | — | WO | disclosed |
| US-20140011810-A1 | Compounds that Modulate EGFR Activity and Methods for Treating or Preventing Conditions Therewith | Gatekeeper Pharmaceuticals, Inc. (US) | 2014-01-09 | — | — | US | disclosed |
| US-20130137709-A1 | Compounds that modulate EGFR activity and methods for treating or preventing conditions therewith | Gatekeeper Pharmaceuticals, Inc. | 2013-05-30 | — | — | US | disclosed |
| US-20060116523-A1 | Silver-containing catalysts for the reaction of substrates with c-c-double bonds | HTE AKTIENGESELLSCHAFT THE HIGH THROUGHPUT EXPERIMENTATION (DE) | 2006-06-01 | — | — | US | disclosed |
| WO-2004062777-A2 | SILVER-CONTAINING CATALYSTS FOR THE REACTION OF SUBSTRATES WITH C-C-DOUBLE BONDS | HTE AKTIENGESELLSCHAFT THE HIGH THROUGHPUT EXPERIMENTATION COMPANY (DE) | 2004-07-29 | — | — | WO | disclosed |